AstraZeneca

By embedding sustainability into everything we do – from the lab to the patient – we’re pushing the boundaries of what science can do to deliver more equitable, resilient and net zero healthcare. Here are seven ways we’re harnessing the power of sustainable science. Explore our sustainable science hub to learn more: https://learn.az/6047WDGJR #WhatScienceCanDo

As leaders in respiratory, our ambition is to transform patient outcomes, while also reducing the carbon footprint of our medicines. That is why we are pleased to share that our industry first, regulatory submission for our inhaled devices using a next-generation propellant with near-zero global warming potential has been accepted by the European Medicines Agency. Transitioning our pMDI portfolio to our next-generation propellant is a key component of our Ambition Zero Carbon strategy. Learn more about our progress in decarbonising respiratory care. #WhatScienceCanDo

The health of our people, society and planet are deeply interconnected. Tackling climate change, advancing health equity and supporting resilient health systems are not just goals—they're necessities. As the world continues to face these complicated challenges, it's clear that we need to act. Science empowers us to understand these complexities and drive improvements for both people and our planet. Through innovation, collaboration and a focus on sustainability, we can create a healthier future for all. Let's work together to make this vision a reality. Join the conversation on building a healthier future. Together, we can make a big difference. https://learn.az/6044sUrAs #WhatScienceCanDo

Congratulations to Iskra Reic, Executive Vice President, Vaccines & Immune Therapies, for being named one of Fierce Pharma's Fiercest Women in Life Sciences 2024. With over 20 years at AstraZeneca and as a Senior Executive Team member since 2017, Iskra’s visionary leadership, has fueled breakthrough vaccines and antibodies, protecting the patients globally from serious viral and bacterial infections. Her dedication to innovation, mentorship and long-term business growth continues to inspire us all. We couldn’t be prouder. Congratulations, Iskra! #WhatScienceCanDo

Millions of people suffer from COPD, a chronic lung disease caused by indoor and outdoor air pollution, second-hand smoke, or smoking. This places a heavy burden on individuals and the planet, yet stigma prevents people from seeking care. Greater understanding can encourage screenings, improve care, and save lives. It's time for governments to prioritise COPD and mortality reduction by developing and funding national respiratory strategies. Be part of the change: https://learn.az/6047s6dM3 #WorldCOPDDay #SpeakUpforCOPD

Our Top 5 position in the Access to Medicine Foundation's latest Access to Medicine Index, reflects the efforts of our colleagues across AstraZeneca to increase equitable and affordable access to life-changing treatments. We are pleased to see the progress made across our sector and remain committed to working with governments, policymakers, healthcare providers and communities, to strengthen health systems and improve equitable and early disease detection, diagnosis and treatment for patients. Find out more: https://learn.az/6043soMZL #AccesstoMedicine

Our goal of eliminating cancer as a cause of death is ambitious and having leaders who champion the cause will help us make it a reality. Please welcome Bob Li to our Oncology team as Global Head of Medical Affairs. Bob will lead the team’s efforts to uncover gaps in scientific evidence and enhance the patient experience, integrating these insights to help advance clinical practice. With more than 15 years of global experience in clinical research and as a thoracic oncologist, he will bring invaluable perspectives as we work to improve care and outcomes for patients. Discover more: https://learn.az/6043s9CZ1

Nancy, a lung cancer patient, shared that she felt guilty for smoking prior to her lung cancer diagnosis, but having the courage to seek treatment when she did has allowed her to live 20 years cancer free. There are over 2.4 million people living with lung cancer globally, many of whom deal with stigma after diagnosis. Anyone can get lung cancer, and nothing should stand in the way of a patient receiving treatment for their disease. Learn more about Nancy’s experience as we aim to eliminate stigma this #LungCancerAwarenessMonth: https://learn.az/6041s96b7

Loono, founded by Kateřina Šédová 10 years ago, runs educational workshops about cancer, cardiovascular disease, and mental & reproductive health in Czechia, helping young people live longer, healthier lives through prevention. The Young Health Programme Lead2030 Challenge grant, given in partnership with One Young World, has helped Loono to develop a mobile app and online educational materials for young people, as well as foster partnerships with relevant organisations. Learn more here: https://learn.az/6044sT67K

A Stage IV lung cancer diagnosis jumpstarted Elden’s journey to achieve his life-long dream of climbing Mount Kinabalu in Malaysia. In a series presented by the Union for International Cancer Control (UICC) and produced for AstraZeneca by BBC StoryWorks, we share the experiences of people like Elden who are changing the perception of what it means to be diagnosed with lung cancer. Learn more about how targeted therapies have helped transform outcomes: https://learn.az/6048sRHtp #LungCancerAwarenessMonth #WhatScienceCanDo #RewritingCancer